Navigation Links
"From Survive to Thrive" campaign seeks to enhance access to lifesaving donor milk in Neonatal Intensive Care Units in 2014
Date:11/22/2013

PHILADELPHIA, Nov. 22, 2013 /PRNewswire-iReach/ -- A forthcoming campaign to enhance access to human milk for premature infants in hospital settings was announced today by Elena Medo, Chair and CEO of Medolac Laboratories during a plenary presentation at the Annual International Meeting of the Academy of Breastfeeding Medicine.  

The Campaign sets an ambitious target to improve access to human milk in Neonatal Intensive Care Units from less than 5% today to 20% by the end of 2014.  "Nothing holds a greater opportunity to improve health outcomes for premature infants than the accessibility of safe, affordable and reliable supply of human milk adapted for their use".

The shortage of human milk in Neonatal Intensive Care Units has been well documented, including in an article published by Ms. Medo in the Journal of Breastfeeding Medicine (Vol. 8, No.5) earlier this month, highlighting the critical shortage of donor milk for very low birth weight (VLBW) infants despite the clear health advantages it brings, particularly by greatly reducing the incidence of gastrointestinal diseases such as sepsis and necrotizing enterocolitis. 

Achievement of this ambitious target will be met by greatly increasing the supply of donor milk through the development of cooperative milk banking.  Elena Medo has been a pioneer of the innovative coop model as a way to give donors a voice, fair compensation for their milk and provide incentive to donors to improve supply. 

Donor milk safety is also a key component of increasing access, since premature infants are often immunocompromised and experience a high risk of infection.  Medolac Laboratories requires blood screening of donor candidates, testing of each donor's milk for disease, contamination and drugs of abuse, testing of pooled donor milk for safety and nutrition as well as the testing of finished product. 
More information about the "From Survive to Thrive" campaign will be made available as Medolac makes progress towards fulfilling its objective in 2014.   

About Medolac:

Our vision is to provide human milk based therapies to critically ill babies and children on a global basis by applying proprietary biopharmaceutical processing methods that preserve the immune components in human milk while providing the safest, highest quality human milk formulations available to babies in need.    Medolac Laboratories is a Delaware registered, public benefit corporation (Neolac Inc. dba Medolac) headquartered at Lake Oswego, Oregon in the Pacific Northwest of the United States. 

Media Contact: Yvonne Arroyo, Medolac Laboratories, 8665997740, Media@medolac.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Medolac Laboratories
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. What Hospitals Must Do to Thrive -- Not Just Survive -- on Medicare Margins
2. Medtech companies urged to evolve business model to survive
3. Elsevier Supports International Crisis Aid Through Pillars of Hope Campaign
4. UV Flu Technologies to Commence a National TV Advertising Campaign
5. Research Triangle Region Debuts Talent Attraction Campaign at BIO 2012
6. Mandy Moore Campaigns for Clean Water, GreenBeanBuddy Encourages Mothers to Help Through the Use of Green Cleaning Products
7. New "GMO Inside" Campaign Denounces Corporate Disinformation Campaign That Defeated Californias Prop 37
8. Adult Stem Cell Therapy Breakthrough Leads to Crowd Funding Campaign on Indiegogo.com for Centagen, Inc.
9. Medbox, Inc. Initiates "Responsible Consumption" Campaign for Marijuana in Recreational States
10. Texas Fertility Center ‘March Dadness’ Campaign Focuses on the Odds of Beating Male Infertility
11. Orexigen Therapeutics Commends the Campaign to End Obesitys Report on Long-term Returns of Obesity Prevention Policies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... , Nov. 30, 2016  Tempus, a technology ... care, and Penn,s Abramson Cancer Center have partnered ... positive response to immunotherapy treatment based on next ... As part of a research collaboration, Tempus will ... melanoma cancer patient data to Penn. Utilizing next-generation ...
(Date:11/30/2016)... 30, 2016 Part of 5m$ Investment ... ... Aptuit, LLC today announced that it had successfully completed ... novel compounds have increased the Screening Collection to over 400,000. ... discovery capabilities of the company. This expansion, complemented by new ...
(Date:11/30/2016)... Woburn, MA (PRWEB) , ... November 30, 2016 ... ... broadband light sources for advanced technology applications, introduces the 5th generation, ultra-bright, Laser-Driven ... the highly successful Laser-Driven Light Source (LDLS™) technology, the EQ-77 offers higher radiance ...
(Date:11/30/2016)... ... November 30, 2016 , ... With growth rates averaging ... after five years and look forward to continuing their expansion in their new office ... area which has been traditionally favoured by the creative industries, so Random42 Scientific Communication ...
Breaking Biology Technology:
(Date:6/9/2016)... , June 9, 2016  Perkotek an innovation leader in attendance control systems ... seamlessly log work hours, for employers to make sure the right employees are actually ... http://photos.prnewswire.com/prnh/20160609/377486LOGO ... ... ...
(Date:6/3/2016)... , June 3, 2016 ... von Nepal hat ... Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung ... in der Produktion und Implementierung von Identitätsmanagementlösungen. ... Ausschreibung im Januar teilgenommen, aber Decatur wurde ...
(Date:6/2/2016)... -- Perimeter Surveillance & Detection Systems, Biometrics ... Support & Other Service  The latest report ... analysis of the global Border Security market . ... $17.98 billion in 2016. Now: In November ... software and hardware technologies for advanced video surveillance. ...
Breaking Biology News(10 mins):